Colorectal cancer staging—time for a re-think on TNM?
Author:
- 4 March 2025
- journal article
- Published by Oxford University Press (OUP) in British Journal of Surgery
- Vol. 112 (3)
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Predicting early extrahepatic recurrence after local treatment of colorectal liver metastasesBritish Journal of Surgery, 2023
- Molecular residual disease and efficacy of adjuvant chemotherapy in patients with colorectal cancerNature Medicine, 2023
- Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-upAnnals of Oncology, 2022
- PD-1 Blockade in Mismatch Repair–Deficient, Locally Advanced Rectal CancerNew England Journal of Medicine, 2022
- Circulating Tumor DNA Analysis Guiding Adjuvant Therapy in Stage II Colon CancerNew England Journal of Medicine, 2022
- Interobserver variation in the classification of tumor deposits in rectal cancer—is the use of histopathological characteristics the way to go?Virchows Archiv, 2021
- Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trialThe Lancet Oncology, 2021
- Pembrolizumab in Microsatellite-Instability–High Advanced Colorectal CancerNew England Journal of Medicine, 2020
- Neoadjuvant immunotherapy leads to pathological responses in MMR-proficient and MMR-deficient early-stage colon cancersNature Medicine, 2020
- Prognostic Effect ofBRAFandKRASMutations in Patients With Stage III Colon Cancer Treated With Leucovorin, Fluorouracil, and Oxaliplatin With or Without CetuximabJAMA Oncology, 2016